Related Experiment Video

Updated: Sep 7, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links

Shalendra Singh1, Praneet Vashishtha1, Nipun Gupta1

  • 1Department of Anaesthesiology and Critical Care, Armed Forces Medical College, Pune, Maharashtra, India.

Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|June 17, 2022
PubMed

Insights

Myasthenia Gravis patients may face severe COVID-19 outcomes. Understanding the interplay between these conditions is crucial for better patient management and treatment strategies.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disease.
  • Severe COVID-19 infection poses significant risks, particularly to vulnerable populations.
  • The interaction between MG and severe COVID-19 remains incompletely understood.

Purpose of the Study:

  • To explore the potential links and interplay between Myasthenia Gravis and severe COVID-19.
  • To identify factors that may influence disease severity in co-infected patients.
  • To highlight gaps in current knowledge regarding this specific patient cohort.

Main Methods:

  • Literature review of existing studies on MG and COVID-19.
  • Analysis of clinical observations and case reports (if applicable).
  • Discussion of immunological and pathophysiological connections.

Main Results:

  • Patients with Myasthenia Gravis may experience a more severe course of COVID-19 infection.
  • Certain MG medications might influence COVID-19 susceptibility or severity.
  • COVID-19 can potentially exacerbate Myasthenia Gravis symptoms.

Conclusions:

  • Further research is essential to elucidate the complex relationship between Myasthenia Gravis and severe COVID-19.
  • Identifying "missing links" can guide clinical practice and therapeutic interventions.
  • Proactive management strategies are needed for MG patients during the COVID-19 pandemic.

Keywords:
COVID-19HydroxychloroquineIntravenous immunoglobulinMyasthenia gravis

More Related Videos

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.5K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.4K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20